In vitro anti-hepatitis B virus effect of Hypericum perforatum L.

被引:14
作者
Pang, Ran [1 ]
Tao, Junyan [2 ]
Zhang, Shuling [1 ]
Zhu, Jiang [3 ]
Yue, Xin [4 ]
Zhao, Lei [1 ]
Ye, Pian [1 ]
Zhu, Ying [4 ]
机构
[1] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Hepatol & Infect Dis, Wuhan 430022, Peoples R China
[2] Hubei Coll Tradit Chinese Med, Coll Pharm, Wuhan 430064, Peoples R China
[3] Food Ind Res Inst Jiangxi Prov, Nanchang 330029, Peoples R China
[4] Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Peoples R China
关键词
hepatitis B virus; Hypericum perforatum L; HBsAg; HBeAg; HBV DNA; HBV promoter; HEPATOCELLULAR-CARCINOMA; PROTECTIVE ACTIVITY; VIRAL LOAD; RISK; EXTRACT; PROTEIN; PROMOTER; CELLS; PLANT;
D O I
10.1007/s11596-010-0118-0
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The anti-hepatitis B virus (HBV) effects and its mechanisms of the ethanol extracts of Hypericum perforatum L. (EHP) in vitro were explored. HepG2 2.2.15 cells, a stable HBV-producing cell line, were cultured as the model system to observe the anti-HBV effect. The viral antigens of cellular secretion, HBsAg and HBeAg, were determined by enzyme linked immunosorbent assay (ELISA). The quantity of HBV-DNA released in the supernatant was assayed by real-time PCR. In order to understand the mechanisms of the suppression of HBV replication, all HBV promoters (Cp, Xp, S1p, S2p and Fp) with luciferase reporter gene were transfected into HepG2 cells respectively. Then the activities of viral promoters were examined by luciferase reporter assay. It was found EHP effectively suppressed the secretion of HBsAg and HBeAg from HepG2 2.2.15 cells in a dose-dependent manner, as well as the extracellular HBV DNA. And EHP could selectively inhibit the activity of HBV promoter Fp. Our data suggest that EHP exerts anti-HBV effects via inhibition of HBV transcription, which helps to elucidate the mechanism underlying the potential therapeutic value of EHP.
引用
收藏
页码:98 / 102
页数:5
相关论文
共 27 条
[1]   Exploiting the RNA interference pathway to counter hepatitis B virus replication [J].
Arbuthnot, P ;
Carmona, S ;
Ely, A .
LIVER INTERNATIONAL, 2005, 25 (01) :9-15
[2]   Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level [J].
Chen, CJ ;
Yang, HI ;
Su, J ;
Jen, CL ;
You, SL ;
Lu, SN ;
Huang, GT ;
Iloeje, UH .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 295 (01) :65-73
[3]   Past HBV viral load as predictor of mortality and morbidity from HCC and chronic liver disease in a prospective study [J].
Chen, Gang ;
Lin, Wenyao ;
Shen, Fumin ;
Iloeje, Uchenna H. ;
London, W. Thomas ;
Evans, Alison A. .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2006, 101 (08) :1797-1803
[4]   Interaction of hepatitis B viral X protein and CCAAT/enhancer-binding protein α synergistically activates the hepatitis B viral enhancer II pregenomic promoter [J].
Choi, BH ;
Park, GT ;
Rho, HM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (05) :2858-2865
[5]   Temporal relationship between hepatitis B virus enhancer II/basal core promoter sequence variation and risk of hepatocellular carcinoma [J].
Chou, Y-C ;
Yu, M-W ;
Wu, C-F ;
Yang, S-Y ;
Lin, C-L ;
Liu, C-J ;
Shih, W-L ;
Chen, P-J ;
Liaw, Y-F ;
Chen, C-J .
GUT, 2008, 57 (01) :91-97
[6]   Risk of recurrence in hepatitis B-related hepatocellular carcinoma: Impact of viral load in late recurrence [J].
Hoshida, Yujin .
JOURNAL OF HEPATOLOGY, 2009, 51 (05) :842-844
[7]   THE STRUCTURE OF HEPATITIS-B ENVELOPE AND MOLECULAR VARIANTS OF HEPATITIS-B VIRUS [J].
HOWARD, CR .
JOURNAL OF VIRAL HEPATITIS, 1995, 2 (04) :165-170
[8]   Predicting cirrhosis risk based on the level of circulating hepatitis B viral load [J].
Iloeje, UH ;
Yang, HI ;
Su, J ;
Jen, CL ;
You, SL ;
Chen, CJ .
GASTROENTEROLOGY, 2006, 130 (03) :678-686
[9]   Pharmacokinetics, safety, and antiviral effects of hypericin, a derivative of St. John's Wort plant, in patients with chronic hepatitis C virus infection [J].
Jacobson, JM ;
Feinman, L ;
Liebes, L ;
Ostrow, N ;
Koslowski, V ;
Tobia, A ;
Cabana, BE ;
Lee, DH ;
Spritzler, J ;
Prince, AM .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (02) :517-524
[10]   Hepatitis B viral core protein activates the hepatitis B viral enhancer II/pregenomic promoter through the nuclear factor κB binding site [J].
Kwon, JA ;
Rho, HM .
BIOCHEMISTRY AND CELL BIOLOGY-BIOCHIMIE ET BIOLOGIE CELLULAIRE, 2002, 80 (04) :445-455